semi-synthetic glycoconjugate vaccine (Glycovax Pharma)

N/A

Report date: 2025/12/12 17:32:09

Base Information

Drug Namesemi-synthetic glycoconjugate vaccine (Glycovax Pharma)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGlycovax Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A